Two empty medical vials and syringe beside an illustrated human brain

Does the Shingles Vaccine Lower Dementia Risk? What the Evidence Shows

I wrote about shingles here in 2012. Back then the vaccine question was simple and slightly boring: there was one shot, it worked reasonably well, and most people over 60 were told to consider it.

The question I get now is different. People do not ask me whether the shingles vaccine prevents shingles. They ask whether it protects the brain.

That is a fair question, the evidence behind it is more interesting than most vaccine headlines, and it has a catch in it that almost nobody reporting on it mentions.

Start with the boring part, because it is the part that matters

Shingles is the chickenpox virus waking up. It sat in a nerve root for decades and then came back out along that nerve, which is why the rash arrives in a band on one side and stops at the midline.

The rash heals. The nerve pain is the problem. Postherpetic neuralgia is burning, electric pain in the same distribution that can outlast the rash by months, occasionally years, and it is genuinely difficult to treat once it settles in. That, not the rash, is the reason to care about this.

The current vaccine is Shingrix, given as two doses. In the ZOE-50 trial across more than 15,000 adults aged 50 and over, efficacy against shingles was 97.2 percent (1). In ZOE-70, in adults 70 and older, it was 89.8 percent, and in the pooled analysis of everyone over 70 across both trials, efficacy against postherpetic neuralgia specifically was 88.8 percent (2).

Those are very good numbers. Vaccines rarely perform like that in the age group where you most want them to work.

It is a reactogenic shot. Roughly one in six people feels properly unwell for a day or two after a dose, sore arm, tired, achy, sometimes feverish. I tell people that in advance, because a person who was warned takes the second dose and a person who was ambushed does not.

The dementia finding, and the catch

Here is where it gets interesting.

In 2025, a group at Stanford published a study in Nature that used an accident of Welsh policy (3). When Wales rolled out the shingles vaccine, eligibility was set by exact date of birth. Anyone born before 2 September 1933 was ineligible, permanently. Anyone born on or after that date was eligible.

Think about what that creates. A person born on 1 September 1933 and a person born on 3 September 1933 are, on average, identical in every way that matters. Same generation, same health, same everything. The only systematic difference between them is that one could get the vaccine and one could not. Uptake went from 0.01 percent in the group one week too old to 47.2 percent in the group one week younger.

That is as close to a randomized trial as you will ever get out of routine health records without running one.

Over seven years, the vaccinated group had a 3.5 percentage point lower probability of a new dementia diagnosis, which works out to a 20 percent relative reduction (3). The effect was stronger in women. The authors then reproduced it in a separate population using death certificates rather than diagnoses, which guards against the finding being an artifact of who happens to get diagnosed.

Now the catch.

Wales was using Zostavax, the old live-attenuated vaccine. That product was withdrawn from the US market in November 2020. It is not what you would be offered today, and the study does not tell you what Shingrix does.

A separate group looked at exactly that, using the rapid switchover from live to recombinant vaccine as its own natural experiment, and found the recombinant vaccine associated with a 17 percent increase in dementia-free time, about 164 extra days without a diagnosis among those who went on to be diagnosed, over six years (4). Again larger in women. I will note, because they note it, that the senior author consults for the manufacturer, and that GSK had no involvement in the study and did not know about it until after acceptance.

What I actually think about it

I think the signal is real and I do not think it should be the reason you get the shot.

Those are compatible positions. The dementia work is observational in design even when it is cleverly built, the mechanism is unproven, and no randomized trial has tested it. Something could still be wrong with it. Meanwhile the case for Shingrix rests on two large randomized controlled trials showing it prevents a disease that causes months of nerve pain, and that case was already sufficient on its own.

So my framing is this. Get it because postherpetic neuralgia is miserable and largely preventable. If the dementia finding holds up, you will have gotten that for free.

What the finding does change is urgency. I used to be relaxed when someone in their early fifties wanted to put it off a few years. I am less relaxed now, because if there is a neurological benefit it presumably accrues with time, and there is no advantage to waiting.

The part that belongs to my day job

Most of my practice is metabolic, and shingles turns out to sit closer to that than it looks.

A meta-analysis of sixteen studies put the risk of shingles in people with diabetes at a pooled relative risk of 1.38 compared with the general population (5). A separate population cohort found that people with diabetes had roughly 1.45 times the risk of postherpetic neuralgia, and that when they got it, it tended to be more severe and more persistent (6).

So the group most likely to get shingles, and most likely to be left with lasting nerve pain afterward, overlaps heavily with the group I see for weight and glucose.

There is a second reason this matters in diabetes that has nothing to do with the vaccine. Postherpetic neuralgia and diabetic peripheral neuropathy feel similar, they get treated with the same drugs, and I have seen the second diagnosis absorb the first. If burning pain shows up in a band, on one side, in a person who also has stocking-glove neuropathy, that is shingles until proven otherwise, whatever the chart already says.

Age 50 is also, not coincidentally, right in the middle of the menopause transition, which is the other half of what I do. If a woman is already in front of me talking about hormone therapy and bone density, the shingles vaccine is a reasonable thing to raise in the same visit, and often nobody has.

If you already have it, the clock is the thing

Antivirals for shingles work best started within 72 hours of the rash appearing. After that the benefit falls off steeply.

That single fact is the strongest argument I know for handling suspected shingles by video. A one-sided painful band of blistering rash with a burning prodrome is one of the more recognizable things in medicine, and a decent photograph plus a history usually settles it. The bottleneck has never been diagnostic difficulty. It has been how long it takes to be seen, and a visit you can get this afternoon beats a better visit on Thursday.

Two exceptions I do not manage remotely. A rash near or in the eye, particularly on the tip of the nose, needs same-day ophthalmology because of the risk to the cornea. Shingles in someone significantly immunocompromised, or a disseminated rash crossing the midline, goes in person.

For patients

If you are 50 or over, you are eligible for Shingrix regardless of whether you remember having chickenpox, and regardless of whether you had the old vaccine years ago.

If you are immunocompromised, the recommendation starts at 19 (7).

Expect to feel rough for a day after each dose, and get the second one anyway. One dose is not the regimen.

If a painful one-sided rash appears, get seen inside three days. Do not wait to see whether it spreads.

For colleagues

The dementia data is worth knowing and worth describing accurately. The strongest causal design was done on a product no longer sold in the United States, and patients who have read a headline usually have not been told that.

Diabetes belongs on the list of reasons to push the vaccine actively rather than mention it in passing.

And check the vaccine history of the metabolic patients. Nobody owns this conversation, so it tends not to happen. I have started treating it as part of the same visit rather than something to refer out, and it costs about ninety seconds.

The Bottom Line

Shingrix prevents shingles about 97 percent of the time in adults over 50, and it prevents postherpetic neuralgia, which is the thing actually worth avoiding. A natural experiment in Wales found 20 percent less dementia over seven years in vaccinated adults, and a second study suggests the current recombinant vaccine carries a similar signal, but the strongest of that evidence came from a live vaccine the United States no longer uses. Get the vaccine for the nerve pain it reliably prevents rather than the dementia it might. If you have diabetes, your risk of both shingles and lasting nerve pain afterward is meaningfully higher, which moves this up the list. And if a one-sided painful rash turns up, the antiviral window is 72 hours.

Related Reading

Shingles: “You Mean I Have Herpes?”

What Does Diabetes Do to Your Skin?

Newly Diagnosed With Type 2 Diabetes: What You Should Know

When to Use Telemedicine vs. Urgent Care: How I Spot the Sick One

Perimenopause and Menopause Symptoms and How to Manage Them

All About Cold Sores (Oral Herpes)

Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Sources

1. Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087-2096. PMID 25916341. https://pubmed.ncbi.nlm.nih.gov/25916341/

2. Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019-1032. PMID 27626517. https://pubmed.ncbi.nlm.nih.gov/27626517/

3. Eyting M, Xie M, Michalik F, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-446. PMID 40175543. https://pubmed.ncbi.nlm.nih.gov/40175543/

4. Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024;30(10):2777-2781. PMID 39053634. https://pubmed.ncbi.nlm.nih.gov/39053634/

5. Huang CT, Lee CY, Sung HY, et al. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(2):586-597. PMID 34536279. https://pubmed.ncbi.nlm.nih.gov/34536279/

6. Wen SY, Ou-Yang C, Hsu CY, et al. Impact of type 1 versus type 2 diabetes on developing herpes zoster and post-herpetic neuralgia: a population-based cohort study. Acta Derm Venereol. 2023;103:adv9400. PMID 37787418. https://pubmed.ncbi.nlm.nih.gov/37787418/

7. Anderson TC, Masters NB, Guo A, et al. Use of recombinant zoster vaccine in immunocompromised adults aged 19 years and older: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2022;71(3):80-84. PMID 35051134. https://pubmed.ncbi.nlm.nih.gov/35051134/

Clustered fluid-filled blisters on reddened skin of the torso

Shingles – “You mean I have Herpes?”

Reviewed and updated August 2026. Originally published March 2012.

I am Scott Rennie, DO, board certified in Family Medicine and Obesity Medicine. I practice entirely by telemedicine, licensed in all 50 states. Most of my work now is weight loss, metabolic health and menopause care. If this was useful, Start here lists what I write about now.

shutterstock_134601161Shingles, also called Herpes zoster is a painful rash caused by the same virus that causes chickenpox.  The term “shingles” comes from the latin word “cingulum” which means belt or girdle; the rash usually appears in a band or belt-like pattern. Singles can occur in people of all ages, but is more common in adults over age 50.  It can also be more common in those people with a weakened immune system. Cause:  After chickenpox goes away, the virus retreats to cells in the nervous system and hides out there quietly for many years.  Later in life, the varicella zoster virus can become active again and cause shingles.  There are many different types of herpes virus and shingles/chickenpox are a different form of herpes than the type that cause cold sores or genital herpes.   You are not at risk for getting cold sores or genital herpes by being around someone who has shingles or chickenpox. Risk of getting shingles:  About 20% of people will get shingles at some point in their life.  Some people actually get the recurrence of shingles multiple times.  Although it only occurs in people who have had chicken pox in the past, sometimes the chickenpox is mild enough that you might not even be aware that you have had it. Weakened immune system:  Certain people are more at risk for developing shingles if their immune system is compromised: 1)   Chemotherapy treatment for cancer 2)   Cancer itself can lower the immune system 3)   HIV 4)   Medications that suppress the immune system – such as after an organ transplantation or medications used to treat rheumatoid arthritis Symptoms:  Parasthesias are unusual sensations that may occur before any rash is noted.  It’s described as a tingling, itching or burning in the area of skin on one side of the body.  Some individuals develop a fever or headache, but many do not.  Within a day or two a rash of blisters occur on one side of the body in a band-like pattern.  The rash may occur on the chest, upper or lower back or even on the face.  If it occurs on the face near the eye, it can permanently affect the vision, so we will often have those patients be seen by an eye doctor. Shingles pain can be mild, moderate or severe and is usually described as a stabbing or burning pain.  The pain usually stays in the area of the rash and can interfere with sleep and daily activities.  Older adults typically have worse pain than younger patients. After 3-4 days the blisters usually become open sores or ulcers.  Rarely, the patient can develop a secondary bacterial infection in the area of the shingles rash.  We treat any underlying bacterial infection with antibiotics.  The sores then crust over and are not infectious after 7-10 days and the rash gradually resolves within 3-4 weeks.  Scarring or skin changes can occur.  Most of the time, no chronic problems occur after someone has a shingles outbreak. Can I catch it from someone else?   You can’t catch shingles from someone else but you can become infected with the varicella zoster virus.  If you’ve never had chickenpox or the vaccine, you can develop it after being in contact with someone who has shingles.  Even inhaling virus particles that are in the air can spread the infection.  If you have had chickenpox or the vaccine, being near someone with shingles will not cause shingles or chickenpox. Possible complications of shingles:  Possible complications of a shingles infection can occur: 1)   Pain called postherpetic neuralgia is the most common complication.  Is is usually described as a burning pain that affects 10-15% of patients after the rash has resolved. 2)   Skin infection from a bacteria can delay healing 3)   Eye complications can occur if the virus is on the face near the eyes Treatment:  There are multiple medications that can be used to treat shingles.  We try to keep the skin clean and dry to decrease the chance of developing a bacterial infection.  Some options might include: 1)   Antivirals such as acyclovir, famciclovir or valacyclovir are most effective when started within 3 days after the rash appears.  They stop the virus from multiplying and speed the healing of skin lesions.  This decreases the amount of pain the patient experiences 2)   Pain medication such as Ibuprofen, Aleve or prescription pain medication may be prescribed Return to work:  If the blisters are on the face, it is best to remain off work until the area has crusted over which is usually 7-10 days.  If the blisters can be covered, you can return to work after you are feeling well.  If you work in a healthcare facility, please consult your healthcare provider. Prevention:  There is a vaccine to help reduce the risk of shingles.  If a shingles infection occurs after the vaccine, it is usually less severe and there is less chances of developing post-herpetic neuralgia.  We recommend the vaccine for adults over age 60.  Even if you are unsure if you had chickenpox, we recommend the vaccine.  We don’t give the vaccine to pregnant women, or those with a weakened immune system.   I hope that you have found this information useful.  Wishing you the best of health,

When the pain outlasts the rash, gabapentin is one of the first drugs offered for postherpetic neuralgia, so it is worth reading where the gabapentin and dementia risk question stands before you start it.

Updated for 2026: The Vaccine in This Post No Longer Exists

That is not an exaggeration. When I wrote this in 2012, the shingles vaccine was Zostavax, a single live vaccine for adults sixty and over. Zostavax was discontinued in the United States on November 18, 2020 (1). You cannot get it. If this post sent you looking for it, that is on me, and here is what replaced it. Shingrix is now the only zoster vaccine available here. It is not live, it is given as two doses two to six months apart, and it is recommended for immunocompetent adults fifty and older (2). Two things people get wrong about it. You still need it if you have already had shingles. Having had it once does not protect you, and plenty of people get it twice. You also still need it if you had Zostavax years ago. Shingrix is recommended regardless (2).

If Your Immune System Is Suppressed

This is the group that had nothing in 2012, and it is the change that matters most. Because Zostavax was a live vaccine, immunocompromised patients could not have it, and they are precisely the people at highest risk. Shingrix is not live. In October 2021 the recommendation was extended to immunocompromised adults nineteen and older (2). The protection is real, though lower than in healthy adults, and it varies by situation. In people who had received their own stem cell transplant it was 68.2 percent. In people with blood cancers, 87.2 percent. In people on immunosuppressants for immune mediated disease, 90.5 percent (2). If you are on a biologic, on chemotherapy, or post transplant and nobody has raised this with you, raise it yourself. The interval can be shortened to one to two months if you need protection sooner. One technical point worth knowing: if the second dose lands less than four weeks after the first it does not count and has to be repeated. If more than six months go by, you do not start over, you just get the second dose (2).

Treatment, and the Seventy Two Hour Window

This part has not changed and it is still the thing that decides how your next few months go. Acyclovir 800 milligrams five times daily, valacyclovir 1,000 milligrams three times daily, or famciclovir 500 milligrams three times daily, all for seven days, and started within seventy two hours of the rash appearing (3). Seventy two hours. That is the whole game. Antivirals started inside that window shorten the illness and reduce the chance of the nerve pain that follows. Started late, they do much less. This is one of the better arguments for a same day video visit. You do not need anyone to touch you to start this, you need somebody to look at the rash quickly and act.

The Pain That Comes After

Postherpetic neuralgia is the reason shingles has a reputation. For what actually helps, the numbers are worth seeing side by side, expressed as how many people need treating for one to benefit. Tricyclics like nortriptyline do best on paper, around three, though roughly a quarter of people stop them over side effects. Pregabalin up to 600 milligrams a day comes in around four. Gabapentin, at a genuinely therapeutic 1,800 to 3,600 milligrams a day, around eight. The clinician applied capsaicin 8 percent patch, around seven. The lidocaine 5 percent patch has a very good safety profile and thinner evidence behind it (3). The gabapentin number is the one I would flag. It works, but only if it is pushed to a real dose. A great deal of gabapentin gets prescribed at 300 milligrams at bedtime, never titrated, and then written off as ineffective. That is an under dosing problem, not a drug problem.

When This Needs More Than a Video Visit

Shingles on the forehead, around the eye, or on the tip of the nose. That last one, the Hutchinson sign, predicts eye involvement, and this needs an ophthalmologist the same day, not tomorrow. A rash crossing more than about three dermatomes or scattered widely, especially if your immune system is suppressed, because that can mean the virus has spread internally. Facial droop, hearing change, or vertigo with a rash in or around the ear, which suggests Ramsay Hunt syndrome. Confusion, a stiff neck, or any neurologic change.

The Bottom Line

If you are fifty or over, or nineteen and over with a suppressed immune system, get Shingrix, two doses, even if you have had shingles before and even if you had the old vaccine. If a rash starts, be seen within seventy two hours. And if you end up on gabapentin for the nerve pain afterward, make sure somebody actually titrates it.

Related Reading

When to Use Telemedicine vs. Urgent Care: How I Spot the Sick One Am I Truly Allergic to Penicillin? All about Cold Sores (Oral Herpes) The Viral Rash – Exanthem How to Manage Chronic Pain Without Relying on Medication

Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Sources

1. CDC. Zostavax discontinued in the United States as of November 18, 2020. https://archive.cdc.gov/www_cdc_gov/vaccines/vpd/shingles/public/zostavax/index.html 2. Anderson TC, et al. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged 19 Years and Older: ACIP Recommendations, United States, 2022. MMWR. 2022;71(3):80-84. https://pmc.ncbi.nlm.nih.gov/articles/PMC8774159/ 3. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. American Family Physician. November 15, 2017. https://www.aafp.org/pubs/afp/issues/2017/1115/p656.html